Journal of Surgery Concepts & Practice >

2020 , Vol. 25 >Issue 02: 159 - 162

DOI: https://doi.org/10.16139/j.1007-9610.2020.02.015

Review

Nutrition support and pharmacologic management in patients with chronic intestinal failure

Expand

Received date: 2020-01-22

  Online published: 2020-04-25

Fold

Cite this article

GAO Xuejin, WANG Xinying . Nutrition support and pharmacologic management in patients with chronic intestinal failure[J]. Journal of Surgery Concepts & Practice, 2020 , 25(02) : 159 -162 . DOI: 10.16139/j.1007-9610.2020.02.015

References

[1] Irving M. Ethical problems associated with the treatment of intestinal failure[J]. Aust N Z J Surg, 1986, 56(5):425-427.
[2] Pironi L, Arends J, Baxter J, et al. ESPEN endorsed re-commendations. Definition and classification of intestinal failure in adults[J]. Clin Nutr, 2015, 34(2):171-180.
[3] Pironi L, Corcos O, Forbes A, et al. Intestinal failure in adults: Recommendations from the ESPEN expert groups[J]. Clin Nutr, 2018, 37(6 Pt A):1798-1809.
[4] Brandt CF, Hvistendahl M, Naimi RM, et al. Home pa-renteral nutrition in adult patients with chronic intestinal failure: the evolution over 4 decades in a tertiary referral center[J]. J Parenter Enteral Nutr, 2017, 41(7):1178-1187.
[5] Pironi L, Konrad D, Brandt C, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey[J]. Clin Nutr, 2018, 37(2):728-738.
[6] 毛琦, 李幼生, 黎介寿, 等. 中国短肠综合征诊疗共识(2016年版,南京)[J]. 中华胃肠外科杂志, 2017, 20(1):1-8.
[7] Jeppesen PB. Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure[J]. J Parenter Enteral Nutr, 2014, 38(1 Suppl):8S-13S.
[8] Bharadwaj S, Tandon P, Rivas JM, et al. Update on the management of intestinal failure[J]. Cleve Clin J Med, 2016, 83(11):841-848.
[9] Buchman AL. Etiology and initial management of short bowel syndrome[J]. Gastroenterology, 2006, 130(2 Suppl 1):S5-S15.
[10] Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation[J]. Gastroenterology, 2003, 124(4):1111-1134.
[11] Duggan CP, Jaksic T. Pediatric intestinal failure[J]. N Engl J Med, 2017, 377(7):666-675.
[12] Joly F, Mayeur C, Messing B, et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297(1):G116-G123.
[13] Billiauws L, Maggiori L, Joly F, et al. Medical and surgical management of short bowel syndrome[J]. J Visc Surg, 2018, 155(4):283-291.
[14] Crenn P, Morin MC, Joly F, et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients[J]. Gut, 2004, 53(9):1279-1286.
[15] Cosnes J, Lamy P, Beaugerie L, et al. Adaptive hyperphagia in patients with postsurgical malabsorption[J]. Gastroenterology, 1990, 99(6):1814-1819.
[16] Briet F, Flourié B, Achour L, et al. Bacterial adaptation in patients with short bowel and colon in continuity[J]. Gastroenterology, 1995, 109(5):1446-1453.
[17] Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon[J]. Gut, 2000, 47(3):370-376.
[18] Martin G, Wallace L, Hartmann B, et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome[J]. Am J Physiol Gastrointest Liver Physiol, 2005, 288(3):G431-G438.
[19] Nightingale JM, Kamm MA, van der Sijp JP, et al. Gastrointestinal hormones in short bowel syndrome. peptide YY may be the“colonic brake” to gastric emptying[J]. Gut, 1996, 39(2):267-272.
[20] 李宁. 肠功能障碍的肠内营养策略[J]. 肠外与肠内营养. 2010, 17(4):193-194.
[21] Wan X, Bi J, Gao X, et al. Partial enteral nutrition preserves elements of gut barrier function, including innate immunity, intestinal alkaline phosphatase (IAP) level, and intestinal microbiota in mice[J]. Nutrients, 2015, 7(8):6294-6312.
[22] Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults[J]. Clin Nutr, 2016, 35(2):247-307.
[23] Gianotti L, Alexander JW, Gennari R, et al. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis[J]. J Parenter Enteral Nutr, 1995, 19(1):69-74.
[24] Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial[J]. Ann Surg, 2005, 242(5):655-661.
[25] Guo M, Li Y, Li J. Effect of growth hormone, glutamine, and enteral nutrition on intestinal adaptation in patients with short bowel syndrome[J]. Turk J Gastroenterol. 2013, 24(6):463-468.
[26] Wang H, Hong T, Li N, et al. Soluble dietary fiber improves energy homeostasis in obese mice by remodeling the gut microbiota[J]. Biochem Biophys Res Commun, 2018, 498(1):146-151.
[27] Billiauws L, Thomas M, Le-Beyec-Le-Bihan J, et al. Intestinal adaptation in short bowel syndrome. What is new?[J]. Nutr Hosp, 2018, 35(3):731-737.
[28] Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel[J]. Lancet, 1994, 343(8894):373-376.
[29] Yang J, Sun H, Wan S, et al. Risk factors for nephrolithia-sis in adults with short bowel syndrome[J]. Ann Nutr Metab, 2019, 75(1):47-54.
[30] Wang X, Tian F, Sun H, et al. Insulin-like growth factor-1 as a nutritional monitoring factor in patients with chronic intestinal failure[J]. Clin Nutr, 2019, 38(4):1737-1744.
[31] Kumpf VJ. Pharmacologic management of diarrhea in patients with short bowel syndrome[J]. J Parenter Enteral Nutr, 2014, 38(1 Suppl):38S-44S.
[32] Kim ES, Keam SJ. Teduglutide: a review in short bowel syndrome[J]. Drugs, 2017, 77(3):345-352.
[33] Sigalet DL, Lam V, Boctor D. The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function[J]. Semin Pediatr Surg, 2010, 19(1):44-49.
[34] Lam K, Schwartz L, Batisti J, et al. Single-center expe-rience with the use of teduglutide in adult patients with short bowel syndrome[J]. J Parenter Enteral Nutr, 2018, 42(1):225-230.
[35] Billiauws L, Bataille J, Boehm V, et al. Teduglutide for treatment of adult patients with short bowel syndrome[J]. Expert Opin Biol Ther, 2017, 17(5):623-632.
[36] Hvistendahl M, Brandt CF, Tribler S, et al. Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome: an open-label pilot study[J]. J Parenter Enteral Nutr, 2018, 42(1):112-121.
Options
Outlines

/

〈 〉